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Abstract  
Sickle cell anemia results from a single amino acid substitution in the gene encoding the β-globin subunit. Polymerization of deoxygenated sickle 
hemoglobin leads to decreased deformability of red blood cells. Hashimoto's thyroiditis is a common thyroid disease now recognized as an auto-
immune thyroid disorder, it is usually thought to be haemolytic autoimmune anemia. We report the case of a 32 years old women admitted for 
chest pain and haemolysis anemia in which Hashimoto's thyroiditis and sickle cell anemia were found. In our observation the patient is a young 
woman whose examination did not show signs of goitre but the analysis of thyroid function tests performed before an auto-immune hemolytic 
anemia (confirmed by a high level of unconjugated bilirubin and a Coombs test positive for IgG) has found thyroid stimulating hormone (TSH) and 
positive thyroid antibody at rates in excess of 4.5 times their normal value. In the same period, as the hemolytic anemia, and before the atypical 
chest pain and anguish they generated in the patient, the search for hemoglobinopathies was made despite the absence of a family history of 
haematological disease or painful attacks in childhood. Patient electrophoresis's led to research similar cases in the family. The mother was the first 
to be analyzed with ultimately diagnosed with sickle cell trait have previously been ignored. This case would be a form with few symptoms because 
the patient does not describe painful crises in childhood or adolescence. 
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About 7% of the world's population's carriers for hemoglobin 
disorders (sickle cell anemia and thalassemia) [1]. Sickle cell anemia 
results from a single amino acid substitution in the gene encoding 
the β-globin subunit. Polymerization of deoxygenated sickle 
hemoglobin leads to decreased deformability of red blood cells [2]. 
It affects individuals of African, Mediterranean, and Asian descent 
and manifests as haemolysis and vaso-occlusion [3]. Adults with 
sickle cell disease (SCD) have the same symptoms as children. 
However, additional disease manifestations may present or worsen 
as patients age, including leg ulcers, sickle retinopathy, 
nephropathy, decreased bone density, thromboembolic 
complications, pulmonary hypertension, cardiac failure, transfusional 
iron overload, and vascular necrosis. Acute Chest Syndrome (ACS), 
often presents with clinical symptoms similar to pneumonia, is 
caused by vaso-occlusion in the pulmonary vasculature and is 
clinically described as the combination of hypoxia, fever, and a new 
infiltrate identified on chest X-ray. However, the clinical symptoms 
of hypoxia and fever often coincide with symptoms of vaso-occlusive 
episodes (especially in patients who receive narcotic medications) 
and may precede the radiographic changes, resulting in delayed 
diagnosis and treatment [3]. Fetal hemoglobin (HbF) is the major 
modifier of the clinical course of sickle cell anemia [4]. Hashimoto's 
thyroiditis is a common thyroid disease now recognized as an auto-
immune thyroid disorder, characterized by goitre with lymphocytic 
infiltration and the presence of thyroid-specific auto-antibodies. It is 
usually thought to be haemolytic autoimmune anemia [5]. We 
report the case of a 32 years old women admitted for chest pain 
and haemolysis anemia in which Hashimoto's thyroiditis and sickle 
cell anemia were found.  
  
  
Patient and observation 
 
A 32 years old female, with none known familial past medical 
history at this time, but a history of cholecystectomy 13 years ago, 
was initially addressed to hematology by the chest department for 
anemia. A few months after the first visit, she was admitted to 
hospital in an emergency setting for dyspnea and chest pain. 
Examination revealed acute respiratory distress syndrome, chest 
pain and jaundice associated with a fever of 38.5 ° C. The initial 
assessment found anemia of 6.9 g / dL, 105 fl VGM, leukocytes to 
25.590 Giga/L with 18.510 Giga/L Neutrophils, 4.360 Giga/L 
Lymphocytis, 2.630 Giga/L Monocytis, 0.9 Giga/L Basophile and 240 
Giga/L Platelets. The coagulation tests were normal, the total 
bilirubin 95mg/L (Normal range: 1-12 mg/L) unconjugated bilirubin 
83mg/L, conjugated bilirubin 12 mg/L (Figure 1), echocardiography 
found a minimal cardiac effusion with an ejection fraction at 58% 
and pulmonary arterial pressure at 31mmHg, normal abdominal 
ultrasound, venous Doppler of lower limbs was normal, the chest CT 
angio-scan did not find a pulmonary embolism but bilateral alveolar 
consolidation predominant on the right associated with minimal 
pericardial thickening and pleural effusion (Figure 2). The bone 
marrow biopsy was normal. The patient started steroid treatment 
but had stopped it by invoking bone pain. The biological exams 
were completed by immunologics tests: Antinuclear Antibody 
(normal), anti DNA native antibody (normal), T3 free hormone 
0.7ng/ml (0.69-2.02ng/ml / T4 free hormone 4.9µg/dl (4.8-
11.6µg/dl) and thyroid-stimulating hormone (TSH) 27.6 mUI/L (4.5 
X Normal range: 0.3-6.2 mUI/L) Antibody Anti-Thyroperoxydase 
151.1 UI/ml (4.5 x Normal range 0-34 UI / ml). The hemoglobin 
electrophoresis found a homozygous sickle cell disease (HbS: 
78.5%, and 18.1% HbF, HbA2 3.4%) (Figure 3). These results led 
us to further questioning of the patient in search of a family history 
of sickle cell disease and painful episodes in childhood or 
adolescence. The patient did not report any painful episodes in 
childhood but had a maternal aunt followed in hematology for sickle 
cell disease. The hemoglobin electrophoresis realised for her mother 
concluded a heterozygous sickle cell anemia (HbS 35, 2%, HbA 





In our observation the patient is a young woman whose 
examination did not show signs of goitre but the analysis of thyroid 
function tests performed before an auto-immune hemolytic anemia 
(confirmed by a high level of unconjugated bilirubin and a Coombs 
test positive for IgG) has found thyroid stimulating hormone (TSH) 
and positive thyroid antibody at rates in excess of 4.5 times their 
normal value. In definitive the diagnosis was hemolytic anemia due 
to Hashimoto's thyroitidis. The incidence of Hashimoto's thyroiditis is 
0.3-1.5 cases per 1000 population per year. The prevalence of 
positive antibody tests in women is greater than 10% and of clinical 
disease at least 2%. Men have one tenth of this prevalence. Clinical 
diagnosis is based on the presence of diffuse goiter (or various 
clinical courses including euthyroidism with goiter, subclinical 
hypothyroidism with goiter, hypothyroidism, adolescent goiter), anti-
thyroid peroxidase Ac, anti-Tg Ac or lymphocytic infiltration on 
cytological examination [5]. In the same period, as the hemolytic 
anemia, and before the atypical chest pain and anguish they 
generated in the patient, the search for hemoglobinopathies was 
made despite the absence of a family history of haematological 
disease or painful attacks in childhood. Patient electrophoresis's led 
to research similar cases in the family. The mother was the first to 
be analyzed with ultimately diagnosed with sickle cell trait have 
previously been ignored. The patient reported that one of her 
maternal aunts was followed in hematology for sickle cell disease. 
Sickle cell anemia symptoms start at 6 months of age (as fetal 
hemoglobin dissipates) with dactylitis (painful swelling of the hands 
or feet), anemia, mild jaundice, or an enlarged spleen. Adults have 
the same symptoms as children. Acute pain episodes have a peak at 
age 20-29 years. Adult patients who report more than three pain 
crises per year have a predicted decreased survival [3]. In our 
patient sickle cell anemia was diagnosed at an unusual age. The 
history of cholecystectomy should have alerted us to a previous 
chronic hemolysis. This case would be a form with few symptoms 
because the patient does not describe painful crises in childhood or 
adolescence. Many genetic factors are involved in the regulation of 
the intensity of the clinical features. One of the best known and 
most studied of these is the Fetal hemoglobin (Hb F). High HbF is 
strongly associated with a reduced rate of acute painful episodes, 
fewer leg ulcers, and longevity [6]. Fetal hemoglobin inhibits the 
polymerization of hemoglobin S and thereby reduces the 
complications of the disease. This is also the protective effect of this 
molecule which is sought when adding the hydroxy urea in the 
management of sickle cell patients. Lower HbF levels correlate with 
overall more severe disease manifestations [7]. Fetal hemoglobin 
concentration higher than 15% prevents sickle globin 
polymerization. The cut-off for defining lower risk of severe 
complications has been estimated at 20% [8]. The estimated value 
at 18% of HbF for this patient seems to play a role in attenuating 
the intensity of the clinical manifestations in spite of the cut-off of 
20%.  
  
Acute Chest Syndrome is an acute lung injury syndrome that occurs 
frequently in patients with SCD. This lung injury syndrome has been 
defined in clinical research studies as a new pulmonary infiltrate on 
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chest X-ray consistent with alveolar consolidation but not 
atelectasis, involving at least one complete lung segment. The 
radiographic abnormality is usually accompanied by one or more 
new signs or symptoms, including chest pain, fever, tachypnea, 
wheezing, cough, or hypoxemia. The etiology of ACS is 
multifactorial. The three primary studied mechanisms include 
pneumonia or systemic infection, fat embolism, and direct 
pulmonary infarction from HbS-containing erythrocytes [9]. In our 
case, a pulmonary embolus was the first suggested diagnosis behind 
the chest symptoms but it was difficult to establish. Indeed 
pulmonary emboli may contribute to pulmonary symptoms 
associated with acute chest syndrome and pulmonary hypertension 
and while identified in up to 50% of autopsies of sickle cell disease 
cases, but only 5% are detected clinically, in part because they are 
difficult to distinguish from in situ thrombosis [10]. Chest pain and 
all other signs that accompanied it and that motivated the 
hospitalization of the patient may respond to a real acute chest 
syndrome in sickle cell disease. This is supported by the radiological 
assessment evidence. The assessment of hemolysis in our patient 
led us to not omit the possibility of sickle cell disease depended on 
the age and positive Coombs test that would have explained the 
hemolysis but not the chest pain. The thyroid has been 
systematically evaluated as would the diagnostic approach to 
hemolysis. Sickle cell patients can develop any kind of pathology. 
Thus the diagnosis of thyroiditis should not be an exception. A case 
of parathyroiditis has also been described in a 17 year old boy with 





This unusual event of discovery of sickle cell disease in an adult who 
had no previous antecedents other than a cholecystectomy is 
witness of hyperhemolysis which illustrates the probability of a 
genetic involvement in the onset of disease manifestations. 
Otherwise independent of its hemolytic character all other causes of 
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Figure 1: right basal opacity on the chest X ray at diagnosis  
Figure 2: chest angioscan at diagnosis showed a bilateral alveolar 
consolidation predominant on the on the right associated with 
minimal pericardial thickening and pleural effusion  
Figure 3: electrophoresis of hemoglobin that revealed a migration 
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Figure 2: chest angioscan at diagnosis showed a bilateral alveolar consolidation 
predominant on the on the right associated with minimal pericardial thickening and 
pleural effusion  
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Figure 3: electrophoresis of hemoglobin that revealed a migration of 
hemoglobin S and conclude to homozygous sickle cell anemia 
 
 
 
 
 
 
 
